Cumulative Effect of Mesenchymal Stem Cells and Heme Oxygenase-1 Inducer in Ameliorating Induced Liver Toxicity in Rats

Liver diseases are most commonly occurring nowadays, that’s why we are in argent need to develop new strategies in treatment. to evaluate the role of MSCs in regenerating liver cells and to clarify the anti-inflammatory role of HO-1 either alone or as a combined therapy with MSCs. 72 rats were divid...

Full description

Bibliographic Details
Main Authors: Ahmed Talaat Abd Elaziz, Hanaa Mohamed Elzahed, Shar Hassan Hassan, Bahaa Eldin A. Khaled, Eman H. Nadwa
Format: Article
Language:English
Published: Islamic Azad University 2020-02-01
Series:Journal of Chemical Health Risks
Subjects:
Online Access:http://www.jchr.org/article_671481_7bca0f9f8fc34a5e4ff15257e0507c62.pdf
Description
Summary:Liver diseases are most commonly occurring nowadays, that’s why we are in argent need to develop new strategies in treatment. to evaluate the role of MSCs in regenerating liver cells and to clarify the anti-inflammatory role of HO-1 either alone or as a combined therapy with MSCs. 72 rats were divided into seven groups (n=10 rats/group) as follows, group1: control rats, group 2: CCL<sub>4</sub>, group 3: CCL<sub>4</sub> that received MSCs group 4: CCL<sub>4</sub> that received HO-1 inhibitor, group 5: CCL<sub>4</sub> that received HO-1 inducer, group 6: CCL<sub>4</sub> that received combined MSCs and HO-1 inhibitor , and group 7: CCL<sub>4</sub> that received combined MSCs and HO-1 inducer. All groups were evaluated histopathologically with assessment of liver functions. The combined MSCs and HO-1 inducer group showed the highest significant results in ALT (p-value ˂0.05), albumin (p-value ˂0.05), HO-1 activity (p-value ˂0.0001), and genes expression compared to other groups.  This is due to the cumulative anti-inflammatory role of both MSCs and HO-1 together with the ability of MSCs to increase the HO-1 expression with further reduction in inflammation and fibrosis. MSCs and HO-1 inducer provide promising tool in treatment of liver disease.
ISSN:2251-6719
2251-6727